CAS: 1056634-68-4 - CYT-387
Formula:C23H22N6O2
InChI:InChI=1S/C23H22N6O2/c24-10-12-25-22(30)18-3-1-17(2-4-18)21-9-11-26-23(28-21)27-19-5-7-20(8-6-19)29-13-15-31-16-14-29/h1-9,11H,12-16H2,(H,25,30)(H,26,27,28)
InChI key:InChIKey=ZVHNDZWQTBEVRY-UHFFFAOYSA-N
SMILES:N#CCNC(=O)C=1C=CC(=CC1)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4
- Synonyms:
- Benzamide, N-(cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]-
- CYT 387 mesylate
- Cyt 11387
- Cyt-0387
- Cyt387
- Gs 0387
- Momelotinib
- N-(Cyanomethyl)-4-[2-(4-morpholinoanilino)pyrimidin-4-yl]benzamide
- N-(Cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide
Ref: 7W-GW7607
| 1mg | 218.00 € | |
| 5mg | 288.00 € | |
| 10mg | 406.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Momelotinib
CAS:1056634-68-4
Momelotinib (LM-1149) is an orally bioavailable small-molecule inhibitor of Janus kinases 1 and 2 (JAK1/2) …
Formula:
C23H22N6O2
Purity:
99.56%
Color and Shape:
Solid
Molecular weight:
414.46
Ref: TM-T1849
| 1mg | 38.00 € | |
| 2mg | 49.00 € | |
| 5mg | 80.00 € | |
| 10mg | 93.00 € | |
| 25mg | 163.00 € | |
| 50mg | 254.00 € | |
| 100mg | 399.00 € | |
| 200mg | 612.00 € | |
| 1ml*10 (DMSO) | 88.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Ref: 4Z-M-297001
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 9 May 2024
CYT 387
CAS:1056634-68-4
Inhibits JAK1 and JAK2 kinases
Formula:
C23H22N6O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
414.18042
Ref: 3D-FC41383
| 5mg | 106.00 € | |
| 10mg | 140.00 € | |
| 25mg | 271.00 € | |
| 50mg | 414.00 € | |
| 100mg | 686.00 € |
Estimated delivery in United States, on Monday 13 May 2024
CYT387
Controlled ProductCAS:1056634-68-4
Formula:
C23H22N6O2
Color and Shape:
White
Molecular weight:
414.46
Ref: TR-C991800
| 250mg | 3,575.00 € |
Estimated delivery in United States, on Wednesday 12 Jun 2024
